Related references
Note: Only part of the references are listed.ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer
Kosuke Shimizu et al.
ONCOLOGY REPORTS (2020)
Calcineurin regulates cyclin D1 stability through dephosphorylation at T286
Takahiro Goshima et al.
SCIENTIFIC REPORTS (2019)
Ligand induced dissociation of the AR homodimer precedes AR monomer translocation to the nucleus
Ryota Shizu et al.
SCIENTIFIC REPORTS (2019)
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
Nadia R. Zgajnar et al.
BIOMOLECULES (2019)
Promotion of Myoblast Differentiation by Fkbp5 via Cdk4 Isomerization
Mercedes Ruiz-Estevez et al.
CELL REPORTS (2018)
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
M. Puhr et al.
ONCOGENE (2016)
Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease
Naihsuan C. Guy et al.
CURRENT MOLECULAR PHARMACOLOGY (2016)
Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51
Steffen Gaali et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Essential role of autoactivation circuitry on Aurora B-mediated H2AX-pS121 in mitosis
Midori Shimada et al.
NATURE COMMUNICATIONS (2016)
Regulation of androgen receptor splice variant AR3 by PCGEM1
Ziqiang Zhang et al.
ONCOTARGET (2016)
Mini-review: Foldosome regulation of androgen receptor action in prostate cancer
Laia Querol Cano et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Steroid up-regulation of FKBP51 and its role in hormone signaling
Tiina Jaaskelainen et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity
Lance A. Stechschulte et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells
Johanny Tonos De Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
FKBP51 and FKBP52 in signaling and disease
Cheryl L. Storer et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells
S. Romano et al.
CELL DEATH AND DIFFERENTIATION (2010)
FKBP51 Promotes Assembly of the Hsp90 Chaperone Complex and Regulates Androgen Receptor Signaling in Prostate Cancer Cells
Li Ni et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A
S. Periyasamy et al.
ONCOGENE (2010)
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
William P. Harris et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins
Ananya Banerjee et al.
BIOCHEMISTRY (2008)
The intersection of steroid receptors with molecular chaperones: Observations and questions
David F. Smith et al.
MOLECULAR ENDOCRINOLOGY (2008)
FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-κB signaling pathway
Wei Jiang et al.
NEOPLASIA (2008)
Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling
Daniel L. Riggs et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The immunophilin Ligands cyclosporin a and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms
Sumudra Periyasamy et al.
ENDOCRINOLOGY (2007)
Essential role for co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology
Weidong Yong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation
S Tranguch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Physiological role for the cochaperone FKBP52 in androgen receptor signaling
J Cheung-Flynn et al.
MOLECULAR ENDOCRINOLOGY (2005)
Androgen mediated regulation and functional implications of FKBP51 expression in prostate cancer
PG Febbo et al.
JOURNAL OF UROLOGY (2005)
FKBP52
TH Davies et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification and validation of novel androgen-regulated genes in prostate cancer
AM Velasco et al.
ENDOCRINOLOGY (2004)
Rapamycin inhibits doxorubicin-induced NF-κB/Rel nuclear activity and enhances the apoptosis of melanoma cells
MF Romano et al.
EUROPEAN JOURNAL OF CANCER (2004)
The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness
TR Hubler et al.
ENDOCRINOLOGY (2003)
The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo
DL Riggs et al.
EMBO JOURNAL (2003)
Dynamic remodeling of transcription complexes by molecular chaperones
RI Morimoto
CELL (2002)
Stabilization of androgen receptor protein is induced by agonist, not by antagonists
T Furutani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP
W Zhu et al.
CARCINOGENESIS (2001)